Abstract:Purpose of the Review
This review aims to summarize the current knowledge of the extracellular matrix remodeling during hepatic fibrosis. We discuss the diverse interactions of the extracellular matrix with hepatic cells and the surrounding matrix in liver fibrosis, with the focus on the molecular pathways and the mechanisms that regulate extracellular matrix remodeling.
Recent Findings
The extracellular matrix not only provides structure and support for t… Show more
“…The altered ECM landscape in liver cirrhosis include the upregulation of collagens (type I, III, IV, V, VI, VIII, X, XI, XII, XIV, XV, XVI, XVIII, XXI), proteoglycans such as versican, decorin, lumican, and glycoproteins including fibulins, fibronectin, and laminins (Dataset EV5 ). Type X and XI collagens (COL10A1 and COL11A2) are the highest up‐regulated collagens, even though type I collagen (COL1A1, COL1A2) is the most abundant protein in the ECM, suggesting that not only the overall abundance but also the quantitative composition of the ECM constituents is altered in cirrhotic liver (Praktiknjo et al , 2018 ; Ortiz et al , 2021 ). To investigate this in a quantitative manner, we extracted all significantly elevated ECM associated proteins in cirrhotic liver and plotted their abundance rank in cirrhotic and healthy liver respectively which revealed 20 proteins whose abundance rank shifted by at least 20 (Fig 7F ).…”
Deeper understanding of liver pathophysiology would benefit from a comprehensive quantitative proteome resource at cell type resolution to predict outcome and design therapy. Here, we quantify more than 150,000 sequence-unique peptides aggregated into 10,000 proteins across total liver, the major liver cell types, time course of primary cell cultures, and liver disease states. Bioinformatic analysis reveals that half of hepatocyte protein mass is comprised of enzymes and 23% of mitochondrial proteins, twice the proportion of other liver cell types. Using primary cell cultures, we capture dynamic proteome remodeling from tissue states to cell line states, providing useful information for biological or pharmaceutical research. Our extensive data serve as spectral library to characterize a human cohort of non-alcoholic steatohepatitis and cirrhosis. Dramatic proteome changes in liver tissue include signatures of hepatic stellate cell activation resembling liver cirrhosis and providing functional insights. We built a web-based dashboard application for the interactive exploration of our resource (www. liverproteome.org).
“…The altered ECM landscape in liver cirrhosis include the upregulation of collagens (type I, III, IV, V, VI, VIII, X, XI, XII, XIV, XV, XVI, XVIII, XXI), proteoglycans such as versican, decorin, lumican, and glycoproteins including fibulins, fibronectin, and laminins (Dataset EV5 ). Type X and XI collagens (COL10A1 and COL11A2) are the highest up‐regulated collagens, even though type I collagen (COL1A1, COL1A2) is the most abundant protein in the ECM, suggesting that not only the overall abundance but also the quantitative composition of the ECM constituents is altered in cirrhotic liver (Praktiknjo et al , 2018 ; Ortiz et al , 2021 ). To investigate this in a quantitative manner, we extracted all significantly elevated ECM associated proteins in cirrhotic liver and plotted their abundance rank in cirrhotic and healthy liver respectively which revealed 20 proteins whose abundance rank shifted by at least 20 (Fig 7F ).…”
Deeper understanding of liver pathophysiology would benefit from a comprehensive quantitative proteome resource at cell type resolution to predict outcome and design therapy. Here, we quantify more than 150,000 sequence-unique peptides aggregated into 10,000 proteins across total liver, the major liver cell types, time course of primary cell cultures, and liver disease states. Bioinformatic analysis reveals that half of hepatocyte protein mass is comprised of enzymes and 23% of mitochondrial proteins, twice the proportion of other liver cell types. Using primary cell cultures, we capture dynamic proteome remodeling from tissue states to cell line states, providing useful information for biological or pharmaceutical research. Our extensive data serve as spectral library to characterize a human cohort of non-alcoholic steatohepatitis and cirrhosis. Dramatic proteome changes in liver tissue include signatures of hepatic stellate cell activation resembling liver cirrhosis and providing functional insights. We built a web-based dashboard application for the interactive exploration of our resource (www. liverproteome.org).
“…Further pointing to a protective action of OEA, we found that IL6 protein levels (Fig. 3e) and transcription of genes involved in liver inflammation and fibrosis – including C-C motif chemokine ligand 2 ( Ccl2 ) [26], interleukin 1β ( Il1b ) [27], and collagen type I α1 ( Col1a1 ) [28] – were attenuated in OEA-treated mice relative to controls (Fig. 3f–h), whereas transcription of the protective factor heme oxygenase 1 ( Hmox1 ) was enhanced (Fig.…”
<b><i>Introduction:</i></b> Previous work suggests the existence of a paracrine signaling mechanism in which histamine released from visceral mast cells into the portal circulation contributes to fasting-induced ketogenesis by stimulating biosynthesis of the endogenous high-affinity PPAR-α agonist oleoylethanolamide (OEA). <b><i>Methods:</i></b> Male C57Bl/6J mice were rendered obese by exposure to a high-fat diet (HFD; 60% fat). We measured histamine, OEA, and other fatty-acid ethanolamides by liquid-chromatography/mass spectrometry, gene transcription by RT-PCR, protein expression by ELISA, neutral lipid accumulation in the liver using Red Oil O and BODIPY staining, and collagen levels using picrosirius red staining. <b><i>Results:</i></b> Long-term exposure to HFD suppressed both fasting-induced histamine release into portal blood and histamine-dependent OEA production in the liver. Additionally, subchronic OEA administration reduced lipid accumulation, inflammatory responses, and fibrosis in the liver of HFD-exposed mice. <b><i>Discussion:</i></b> The results suggest that disruption of histamine-dependent OEA signaling in the liver might contribute to pathology in obesity-associated liver steatosis.
“…The altered ECM landscape in liver cirrhosis include the upregulation of collagens (type I, III, IV, V, VI, VIII, X, XI, XII, XIV, XV, XVI, XVIII, XXI), proteoglycans such as versican, decorin, lumican, and glycoproteins including fibulins, fibronectin and laminins (Dataset EV5). Type X and XI collagens (COL10A1 and COL11A2) are the highest up-regulated collagens, even though type I collagen (COL1A1, COL1A2) is the most abundant protein in the ECM, suggesting that not only the overall abundance but also the quantitative composition of the ECM constituents is altered in cirrhotic liver (Ortiz et al , 2021; Praktiknjo et al , 2018). To investigate this in a quantitative manner, we extracted all significantly elevated ECM associated proteins in cirrhotic liver and plotted their abundance rank in cirrhotic and healthy liver respectively which revealed 20 proteins whose abundance rank shifted by at least 20 (Fig 7f).…”
Deeper understanding of liver pathophysiology would benefit from a comprehensive quantitative proteome resource at cell-type resolution to predict outcome and design therapy. Here, we quantify more than 150,000 sequence-unique peptides aggregated into 10,000 proteins across total liver, the major liver cell types, time-course of primary cell cultures and liver disease states. Bioinformatic analysis reveals that half of hepatocyte protein mass is comprised of enzymes and 23% of mitochondrial proteins, twice the proportion of other liver cell types. Using primary cell cultures, we capture dynamic proteome remodeling from tissue states to cell line states, providing useful information for biological or pharmaceutical research. Our extensive data serves as spectral library to characterize a human cohort of non-alcoholic steatohepatitis and cirrhosis. Dramatic proteome changes in liver tissue include signatures of stellate cell activation resembling liver cirrhosis and providing functional insights. We built a web-based dashboard application for the interactively exploration of our resource.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.